{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-338438","form_type":"8-K","ticker":"SLDB","cik":"0001707502","company_name":"Solid Biosciences Inc.","filed_at":"2026-08-06T21:15:48+00:00","discovered_at":"2026-08-06T21:18:00.331089+00:00","generated_at":"2026-08-06T21:18:10.798274+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Solid Biosciences upsizes ATM equity facility to $200M; $85M already sold","bullets":["Filed prospectus supplement for up to $200M in common stock sales under existing ATM agreement with Jefferies.","Prior supplement for $85M exhausted; $85M in gross proceeds already raised.","New supplement replaces prior; no further sales under old supplement.","Legal opinion from WilmerHale attached as Exhibit 5.1.","Shares registered under existing shelf registration statement (S-3)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-338438","json":"https://secwatch.observer/filing/0001193125-26-338438.json","markdown":"https://secwatch.observer/filing/0001193125-26-338438.md","text":"https://secwatch.observer/filing/0001193125-26-338438.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526338438/0001193125-26-338438-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1707502/000119312526338438/d177624d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T21:18:10.798274+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}